Skip to content

Study · Not a test of the peptide alone · 1986

1 result

[Use of thymalin and heparin in acute peritonitis].

Kokotov IuK, Budazhabon GB, Kuznik BI, Darenskiĭ DI, Morozov VG

Vestnik khirurgii imeni I. I. Grekova1 Feb 1986

PMID3754668 (opens in a new tab)PepBankPUB-03754668

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In acute peritonitis patients, thymalin alone or with heparin facilitated quicker arrest of the pathological process and clinical and laboratory symptoms.

    In plain wordsIn acute peritonitis patients, thymalin alone or with heparin helped the disease process and symptoms resolve faster.

    Peptide
    Thymalin
    Outcome
    Direction not reportedArrest of pathological process and symptoms
    Study

    n = 63

    Patients with acute peritonitis
    Outcome group
    Gastrointestinal protection · Gastrointestinal

    Source sentences

    Summary
    Results of the investigation of parameters of cell and humoral immunity and coagulogram in 63 patients with acute peritonitis have shown that thymalin when used solely or in combination with heparin facilitates quicker arrest of the pathological process, its clinical and laboratory symptoms.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.